JLSB EndNote Style
Manuscript Template (.doc)
Sample Articles
Declaration form
Policies and Publication Ethics
altaltaltalt

Instructions for Authors

Manuscript as Original Research Paper, Review and Case Reports are invited for rapid peer-review publishing in the Journal of Life Science and Biomedicine. Considered subject areas include: Biocontrol, Biochemistry, Biotechnology, Bioengineering, Neurobiology... view full aims and scope

Submission

The manuscript and other correspondence should preferentially be submit online. Please embed all figures and tables in the manuscript to become one single file for submission. nce submission is complete, the system will generate a manuscript ID and will send an email regarding your submission. Meanwhile, the authors can submit or track articles via editors [at] jlsb.science-line.com ; jlsb.editors [at] gmail.com. All manuscripts must be checked (by English native speaker) and submitted in English for evaluation (in totally confidential and impartial way).

Supplementary information:
The online submission form allows supplementary information to be submitted together with the main manuscript file and covering letter. If you have more than one supplementary files, you can submit the extra ones by email after the initial submission. Author guidelines are specific for each journal. Our Word template can assist you by modifying your page layout, text formatting, headings, title page, image placement, and citations/references such that they agree with the guidelines of journal. If you believe your article is fully edited per journal style, please use our MS Word template before submission. Supplementary materials may include figures, tables, methods, videos, and other materials. They are available online linked to the original published article. Supplementary tables and figures should be labeled with a "S", e.g. "Table S1" and "Figure S1". The maximum file size for supplementary materials is 10MB each. Please keep the files as small possible to avoid the frustrations experienced by readers with downloading large files.

Submission to the Journal is on the understanding that:
1.The article has not been previously published in any other form and is not under consideration for publication elsewhere;
2.All authors have approved the submission and have obtained permission for publish work.
3.Researchers have proper regard for conservation and animal welfare considerations. Attention is drawn to the 'Guidelines for the Treatment of Animals in Research and Teaching'. Any possible adverse consequences of the work for populations or individual organisms must be weighed against the possible gains in knowledge and its practical applications. If the approval of an ethics committee is required, please provide the name of the committee and the approval number obtained.

Ethics Committee Approval
Experimental research involving human or animals should have been approved by author's institutional review board or ethics committee. This information can be mentioned in the manuscript including the name of the board/committee that gave the approval. Investigations involving humans will have been performed in accordance with the principles of Declaration of Helsinki. And the use of animals in experiments will have observed the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education by the New York Academy of Sciences, Ad Hoc Animal Research Committee. If the manuscript contains photos or parts of photos of patients, informed consent from each patient should be obtained. Patient's identities and privacy should be carefully protected in the manuscript.

.

JLSB-1094_-Acrochaetium_sp._RhodophytaGraphical Abstract
Authors should provide a graphical abstract (a beautifully designed feature figure) to represent the paper aiming to catch the attention and interest of readers. Graphical abstract will be published online in the table of content. The graphical abstract should be colored, and kept within an area of 12 cm (width) x 6 cm (height) or with similar format. Image should have a minimum resolution of 300 dpi and line art 1200dpi.
Note:
Height of the image should be no more than the width. Please avoid putting too much information into the graphical abstract as it occupies only a small space. Authors can provide the graphical abstract in the format of PDF, Word, PowerPoint, jpg, or png, after a manuscript is accepted for publication. For preparing a Professional Graphical Abstract, please click here.


alt


Presentation of the article

Main Format
First page of the manuscripts must be properly identified by the title and the name(s) of the author(s). It should be typed in Times New Roman (font sizes: 17pt in capitalization for the title, 10pt for the section headings in the body of the text and the main text, double spaced, in A4 format with 2cm margins (both doc./docx formats). All pages and lines of the main text should be numbered consecutively throughout the manuscript. Abbreviations in the article title are not allowed. Manuscripts should be arranged in the following order:

1. TITLE (brief, attractive and targeted);
2. Name(s) and Affiliation(s) of author(s) (including post code and corresponding Email);
3. ABSTRACT;
4. Key words (separate by semicolons; or comma,);
5. Abbreviations (those used throughout the manuscript);
6. INTRODUCTION (clear statement of the problem, the relevant literature on the subject, and the proposed approach or solution);
7. METHODOLOGY (should be complete enough to allow experiments to be reproduced);
8. RESULTS;
9. DISCUSSION;
10. CONCLUSION;
11. DECLARATIONS (Acknowledgements, Consent to publish, Competing interests, Authors' contributions, and Availability of data etc.)
12. REFERENCES;
13. Tables;
14. Figures;
15. Graphs

Results and Discussion can be presented jointly.
Discussion and Conclusion can be presented jointly.

Article Sections Format

Title should be a brief phrase describing the contents of the paper. The first letter of each word in title should use upper case. The Title Page should include the author(s)'s full names and affiliations, the name of the corresponding author along with phone and e-mail information. Present address (es) of author(s) should appear as a footnote.

Abstract should be informative and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions. The abstract should be 150 to 300 words in length. Complete sentences, active verbs, and the third person should be used, and the abstract should be written in the past tense. Standard nomenclature should be used and abbreviations should be avoided. No literature should be cited.

Following the abstract, about 3 to 8 key words that will provide indexing references should be listed.

Introduction should provide a clear statement of the problem, the relevant literature on the subject, and the proposed approach or solution. It should be understandable to colleagues from a broad range of scientific disciplines.

Material and Method should be complete enough to allow experiments to be reproduced. However, only truly new procedures should be described in detail; previously published procedures should be cited, and important modifications of published procedures should be mentioned briefly. Capitalize trade names and include the manufacturer's name and address. Subheadings should be used. Methods in general use need not be described in detail. The ethical approval for using human and animals in the researches should be indicated in this section with a separated title.

Results should be presented with clarity and precision. The results should be written in the past tense when describing findings in the author(s)'s experiments. Previously published findings should be written in the present tense. Results should be explained, but largely without referring to the literature. In case of the effectiveness of a particular drug or other substances as inhibitor in biological or biochemical processes, the results should be provided as IC50 (half maximal inhibitory concentration) or similar appropriate manner.

Discussion should interpret the findings in view of the results obtained in this and in past studies on this topic. State the conclusions in a few sentences at the end of the paper. The Results and Discussion sections can include subheadings, and when appropriate, both sections can be combined.

Conclusion should be brief and tight about the importance of the work or suggest the potential applications and extensions. This section should not be similar to the Abstract content.

Declarations including Acknowledgements, Authors' contributions, Competing interests, Consent to publish, and Availability of data etc.

Tables should be kept to a minimum and be designed to be as simple as possible. Tables are to be typed double-spaced throughout, including headings and footnotes. Each table should be on a separate page, numbered consecutively in Arabic numerals and supplied with a heading and a legend. Tables should be self-explanatory without reference to the text. The details of the methods used in the experiments should preferably be described in the legend instead of in the text. The same data should not be presented in both table and graph forms or repeated in the text.

Figure legends should be typed in numerical order on a separate sheet. Graphics should be prepared using applications capable of generating high resolution GIF, TIFF, JPEG or PowerPoint before pasting in the Microsoft Word manuscript file. Use Arabic numerals to designate figures and upper case letters for their parts (Figure 1). Begin each legend with a title and include sufficient description so that the figure is understandable without reading the text of the manuscript. Information given in legends should not be repeated in the text.

Declarations

Please ensure that the sections: Ethics (and consent to participate, if any), Acknowledgements, Authors' contributions, Competing interests, Consent to publish, Availability of data and materials are included at the end of your manuscript in a Declarations section.

Acknowledgements
We encourage authors to include an Acknowledgements section. Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include their source(s) of funding. Please also acknowledge anyone who contributed materials essential for the study. Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements. Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section. Authors must describe the role of the funding body, if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.

Authors’ contributions
For manuscripts with more than one author, JLSB require an Authors' Contributions section to be placed after the Acknowledgements section.
An 'author' is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.
We suggest the following format/example (please use initials to refer to each author's contribution): AB carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in the sequence alignment. ES participated in the design of the study and performed the statistical analysis. FG conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
For authors that equally participated in a study please write 'All/Both authors contributed equally to this work.' Contributors who do not meet the criteria for authorship should be listed in an acknowledgements section.

Competing interests
Competing interests that might interfere with the objective presentation of the research findings contained in the manuscript should be declared in a paragraph heading "Competing interests" (after Acknowledgment or Authors’ Contributions sections). Examples of competing interests are ownership of stock in a company, commercial grants, board membership, etc. If there is no competing interest, please use the statement "The authors declare that they have no competing interests.".

altJournal of Life Science and Biomedicine adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). According to the ICMJE authorship criteria should be based on 1) substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published. Authors should meet conditions 1, 2 and 3. It is a requirement that all authors have been accredited as appropriate upon submission of the manuscript. Contributors who do not qualify as authors should be mentioned under Acknowledgements.

Consent to publish
Please include a ‘Consent for publication’ section in your manuscript. If your manuscript contains any individual person’s data in any form (including individual details, images or videos), consent to publish must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent to publish. You can use your institutional consent form or our consent form if you prefer. You should not send the form to us on submission, but we may request to see a copy at any stage (including after publication). If your manuscript does not contain any individual persons data, please state “Not applicable” in this section.

Change in authorship
We do not allow any change in authorship after provisional acceptance. We cannot allow any addition, deletion or change in sequence of author name. We have this policy to prevent the fraud.

Data deposition
Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article.


alt

REFERENCES

A reference style for EndNote may be found here. References should be numbered consecutively and cited in the text by number in square brackets [1, 2] (not by author and date). References should not be formatted as footnotes. Avoid putting personal communications and unpublished observations as references. All the cited papers in the text must be listed in References. All the papers in References must be cited in the text. Where available, URLs for the references should be provided.

Examples (at the text):
Smit [1] ...; Smit and Janak [2]…; Nurai et al. [3] reported that ; ... [1], --- [2, 3], --- [3-7].
The references at the end of this document are in the preferred referencing style. Give all authors’ names; do not use “et al.” unless there are six authors or more. Use a space after authors’ initials. Papers that have not been published should be cited as “unpublished”. Papers that have been accepted for publication, but not yet specified for an issue should be cited as “to be published”. Papers that have been submitted for publication should be cited as “submitted for publication”. Capitalize only the first word in a paper title, except for proper nouns and element symbols. For papers published in translation journals, please give the English citation first, followed by the original foreign-language citation.

Examples (at References section):
For Journals
:
1.
Sukiman F, Imy SC and Hilman A. 2014. Short Communication: Growth of Seaweed Eucheuma cottonii in Multitrophic Sea Farming Systems at Gerupuk Bay, Central Lombok, Indonesia. Bioscience. 6(1): 82-85.
2.
Hasan V, Sri Widodo M and Semedi B. 2015. Oocyte Diamater Distribution and Fecundity of Javaen Barb (Systomus Orphoides) at the Start of Rainy Season in Lenteng River, East Java, Indonesia insurance. J. Life Sci. Biomed. 5(2): 39-42.

For In press manuscripts (maximum 2):
Hasan V, Sri Widodo M and Semedi B. 2015. Oocyte Diamater Distribution and Fecundity of Javaen Barb (Systomus Orphoides) at the Start of Rainy Season in Lenteng River, East Java, Indonesia insurance. In press.

For symposia reports and abstracts:
Cruz EM, Almatar S, Aludul EK and Al-Yaqout A. 2000. Preliminary Studies on the Performance and Feeding Behaviour of Silver Pomfret (Pampus argentens euphrasen) Fingerlings fed with Commercial Feed and Reared in Fibreglass Tanks. Asian Fisheries Society Manila, Philippine 13: 191-199.

For Conference:
Skinner J, Fleener B and Rinchiuso M. 2003. Examining the Relationship between Supervisors and Subordinate Feeling of Empowerment with LMX as A Possible Moderator. 24th Annual Conference for Industrial Organizational Behavior.

For Book:
Russell, Findlay E, 1983. Snake Venom Poisoning, 163, Great Neck, NY: Scholium International. ISBN 0-87936-015-1.

For Web Site:
Bhatti SA and Firkins JT. 2008. http://www.ohioline.osu.edu/sc1156_27.hmtl.

Nomenclature and Abbreviations:
Nomenclature should follow that given in NCBI web page and Chemical Abstracts. Standard abbreviations are preferable. If a new abbreviation is used, it should be defined at its first usage. Abbreviations should be presented in one paragraph, in the format: "term: definition". Please separate the items by ";".
E.g. ANN: artificial neural network; CFS: closed form solution; ...

Abbreviations of units should conform with those shown below:

Decilitre
dl
Kilogram
kg
Milligram
mg
hours
h
Micrometer
mm
Minutes
min
Molar
mol/L
Mililitre
ml
Percent
%
.

Other abbreviations and symbols should follow the recommendations on units, symbols and abbreviations: in “A guide for Biological and Medical Editors and Authors (the Royal Society of Medicine London 1977). Papers that have not been published should be cited as “unpublished”. Papers that have been accepted for publication, but not yet specified for an issue should be cited as “to be published”. Papers that have been submitted for publication should be cited as “submitted for publication".


Formulae, numbers and symbols

  1. Typewritten formulae are preferred. Subscripts and superscripts are important. Check disparities between zero (0) and the letter 0, and between one (1) and the letter I.
  2. Describe all symbols immediately after the equation in which they are first used.
  3. For simple fractions, use the solidus (/), e.g. 10 /38.
  4. Equations should be presented into parentheses on the right-hand side, in tandem.
  5. Levels of statistical significance which can be used without further explanations are *P < 0.05, **P < 0.01, and ***P < 0.001.
  6. In the English articles, a decimal point should be used instead of a decimal comma.
  7. Use Symbol fonts for "±"; "≤" and "≥" (avoid underline).
  8. In chemical formulae, valence of ions should be given, e.g. Ca2+ and CO32-, not as Ca++ or CO3.
  9. Numbers up to 10 should be written in the text by words. Numbers above 1000 are recommended to be given as 10 powered x.
  10. Greek letters should be explained in the margins with their names as follows: Αα - alpha, Ββ - beta, Γγ - gamma, Δδ - delta, Εε - epsilon, Ζζ - zeta, Ηη - eta, Θθ - theta, Ιι - iota, Κκ - kappa, Λλ - lambda, Μμ - mu, Νν - nu, Ξξ - xi, Οο - omicron, Ππ - pi, Ρρ - rho, Σσ - sigma, Ττ - tau, Υυ - ipsilon, Φφ - phi, Χχ - chi, Ψψ - psi, Ωω - omega.Please avoid using math equations in Word whenever possible, as they have to be replaced by images in xml full text.

.

alt


Review/Decisions/Processing/Policy

Firstly, all manuscripts will be checked by Docol©c, a plagiarism finding tool. The received papers with plagiarism rate of more than 30% will be rejected. Manuscripts that are judged to be of insufficient quality or unlikely to be competitive enough for publication will be returned to the authors at the initial stage. The remaining manuscripts go through a single-blind review process by external reviewers selected by section editor of JLSB, who are research workers specializing in the relevant field of study. One unfavourable review means that the paper will not be published and possible decisions are: accept as is, minor revision, major revision, or reject. The corresponding authors should submit back their revisions within 14 days in the case of minor revision, or 30 days in the case of major revision. Manuscripts with significant results are typically published at the highest priority. The editor who received the final revisions from the corresponding authors shall not be hold responsible for any mistakes shown in the final publication.

Plagiarism
There is an instant policy towards plagiarism (including self-plagiarism) in our journals. Manuscripts are screened for plagiarism by Docol©c, before or during publication, and if found they will be rejected at any stage of processing. If we discovered accidental duplicates of published article(s) that are determined to violate our journal publishing ethics guidelines (such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like), the article will be “Withdrawn” from SCIENCELINE database. Withdrawn means that the article content (HTML and PDF) is removed and replaced with a HTML page and PDF simply stating that the article has been withdrawn according to the Scienceline Policy on Published Article Withdrawal.

Date of issue
All accepted articles are published bimonthly around 25th of January, March, May, July, September and November, each year in full text on the internet.

Publication charge & the waiver policy
Articles of Journal of Life Science and Biomedicine are freely accessible. No submission and peer-reviewing charges are required. Publication of short reports and letter are free of charge; however, a negligible editor fee (90 USD) will be applied for long research and review papers before copyediting and publication. The editor fee will also be waived for invited authors, authors of hot papers, and corresponding authors who are editorial board members of the Journal of Life Science and Biomedicine. The Journal will consider requests to waive the fee for cases of financial hardship (for high quality manuscripts and upon acceptance for publication). Requests for waiver of the submission fee must be submitted via individual cover letter by the corresponding author and cosigned by an appropriate institutional official to verify that no institutional or grant funds are available for the payment of the fee. Letters including the manuscript title and manuscript ID number should be sent to: editors [at] jlsb.science-line.com. It is expected that waiver requests will be processed and authors will be notified within two business day.

The OA policy
Journal of Life Science and Biomedicine is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of Open Access. The journal also allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.

.


Paper Submission Flow

Paper_Submission_Flow_001

Submission Preparation Checklist

Authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to the following guidelines.
The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
The submission file is in Microsoft Word, RTF, or PDF document file format.
Where available, URLs for the references have been provided.
The text is single-spaced; uses a 12-point font; and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.


(Revised on 22 June 2018)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.Creative Commons License